
IGM Biosciences IGMS
IGM Biosciences ROCE | IGMS
ROCE Jährlich IGM Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -432.99 | -129.63 | -79.35 | -67.5 | -21.81 | -17.62 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -17.62 | -432.99 | -124.82 |
ROCE Vierteljährlich IGM Biosciences
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7875.72 | -8004.49 | -183.23 | -128.04 | -112.54 | -97.58 | -87.06 | -86.09 | -59.62 | -75.1 | -68.67 | -61.81 | -36.41 | -42.89 | -32.79 | -25.86 | -21.81 | -21.97 | -21.02 | -20.32 | -18.52 | 1.85 | 16.24 | 30.33 | 40.21 | 9.94 | 9.71 | 6.81 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 40.21 | -8004.49 | -605.94 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbbVie
ABBV
|
-461.01 | $ 263.04 | 0.49 % | $ 465 B | ||
|
AbCellera Biologics
ABCL
|
-16.8 | $ 11.41 | 2.15 % | $ 3.41 B | ||
|
Фармсинтез
LIFE
|
-4.03 | - | - | - | ||
|
Aclaris Therapeutics
ACRS
|
-74.09 | $ 5.53 | 6.02 % | $ 678 M | ||
|
ADC Therapeutics SA
ADCT
|
65.38 | $ 1.09 | 3.74 % | $ 139 M | ||
|
Amryt Pharma plc
AMYT
|
-5.86 | - | - | $ 621 M | ||
|
Evelo Biosciences
EVLO
|
2172.8 | - | -14.46 % | $ 27.9 M | ||
|
Allakos
ALLK
|
-155.07 | - | - | $ 28.6 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.5 | - | - | $ 231 M | ||
|
Clovis Oncology
CLVS
|
18.9 | - | -7.23 % | $ 13 M | ||
|
Chimerix
CMRX
|
-79.36 | - | - | $ 756 M | ||
|
Concert Pharmaceuticals
CNCE
|
-69.06 | - | - | $ 401 M | ||
|
ADMA Biologics
ADMA
|
40.11 | $ 8.61 | 0.16 % | $ 2.05 B | ||
|
Eiger BioPharmaceuticals
EIGR
|
496.51 | - | -9.21 % | $ 2.55 M | ||
|
89bio
ETNB
|
-95.97 | - | - | $ 1.55 B | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-187.83 | - | - | $ 384 M | ||
|
Fusion Pharmaceuticals
FUSN
|
-44.6 | - | - | $ 1.41 B | ||
|
Guardion Health Sciences
GHSI
|
-53.23 | - | -0.31 % | $ 3.64 M | ||
|
Genocea Biosciences
GNCA
|
-192.4 | - | -15.0 % | $ 3.04 M | ||
|
Gritstone Oncology
GRTS
|
-269.28 | - | 0.42 % | $ 213 M | ||
|
G1 Therapeutics
GTHX
|
-111.7 | - | - | $ 370 M | ||
|
Harpoon Therapeutics
HARP
|
-1265.51 | - | - | $ 763 M | ||
|
Humanigen
HGEN
|
146.06 | - | -81.12 % | $ 4.28 M | ||
|
HOOKIPA Pharma
HOOK
|
-88.88 | - | -6.92 % | $ 79.4 M | ||
|
Intercept Pharmaceuticals
ICPT
|
-20.32 | - | - | $ 643 M | ||
|
IMV
IMV
|
-79.29 | - | - | $ 13.1 M | ||
|
Intra-Cellular Therapies
ITCI
|
-10.16 | - | - | $ 13.6 B | ||
|
Kinnate Biopharma
KNTE
|
-76.05 | - | - | $ 123 M | ||
|
Chinook Therapeutics
KDNY
|
-41.88 | - | - | $ 2.6 B | ||
|
Kaleido Biosciences
KLDO
|
-826.5 | - | -3.69 % | $ 12.4 M | ||
|
Kronos Bio
KRON
|
-106.06 | - | 1.49 % | $ 50.8 M | ||
|
Karuna Therapeutics
KRTX
|
-39.45 | - | - | $ 12.2 B | ||
|
Landos Biopharma
LABP
|
-71.49 | - | 0.58 % | $ 144 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
-32.71 | - | - | $ 154 M | ||
|
LogicBio Therapeutics
LOGC
|
-126.88 | - | - | $ 229 M | ||
|
Lumos Pharma
LUMO
|
-134.09 | - | - | $ 35.3 M | ||
|
Merrimack Pharmaceuticals
MACK
|
-10.87 | - | - | $ 216 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
102.23 | - | - | $ 23.9 M | ||
|
Mirati Therapeutics
MRTX
|
-76.22 | - | - | $ 3.3 B | ||
|
NexImmune
NEXI
|
-939.5 | - | 70.13 % | $ 4.12 M | ||
|
9 Meters Biopharma
NMTR
|
-1750.31 | - | -42.97 % | $ 1.05 M | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
-67.64 | - | -37.48 % | $ 476 K | ||
|
Nymox Pharmaceutical Corporation
NYMX
|
63.22 | - | -19.68 % | $ 18.4 M | ||
|
ObsEva SA
OBSV
|
-182.2 | - | -15.52 % | $ 10.5 M | ||
|
Oncorus
ONCR
|
-126.46 | - | -8.54 % | $ 3.19 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-604.93 | - | 31.87 % | $ 1.61 M | ||
|
Oncternal Therapeutics
ONCT
|
-138.81 | - | -24.12 % | $ 1.56 M | ||
|
Opiant Pharmaceuticals
OPNT
|
11.01 | - | - | $ 109 M | ||
|
Orchard Therapeutics plc
ORTX
|
-129.33 | - | 1.02 % | $ 90.8 M |